T. Pal et al., Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: A hospital-based study, J CLIN END, 86(11), 2001, pp. 5307-5312
The genetic basis for nonmedullary forms of thyroid cancer (NMTC) is less w
ell established than that of medullary thyroid cancer. However, epidemiolog
ical and family studies suggest that a proportion of NMTC may be due to inh
erited predisposition. To estimate the familial risk of thyroid cancer, we
conducted a hospital-based case-control study at the Princess Margaret Hosp
ital in Toronto, Ontario, Canada, and at 2 university hospitals in Montreal
, Quebec, Canada. We obtained pedigrees from 339 unselected patients diagno
sed with NMTC and from 319 unaffected ethnically matched controls. Family h
istories of cancer were obtained from the cases and controls for 3292 first
degree relatives of cases and controls. Seventeen cases (5.0%) and 2 contr
ols (0.6%) reported at least one first degree relative with thyroid cancer.
In relatives of patients with thyroid cancer, the incidence of any type of
cancer (including NMTC) was 38% higher than in relatives of controls (incid
ence rate ratio, 1.4; 95% confidence interval, 1.1-1.7). The relative risk
for thyroid cancer was 10-fold higher in relatives of cancer patients than
in controls (incidence rate ratio, 10.3; 95% confidence interval, 2.2-47.6)
.
Our findings suggest that hereditary or other familial factors are importan
t in a small proportion of NMTC. Molecular studies are needed to determine
the genetic basis of cancer susceptibility in these families.